Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
224
Total Claims
$2,144
Drug Cost
123
Beneficiaries
$17
Cost/Patient
Risk Score Breakdown 30/100
Score components are additive. Read full methodology
Peer Comparison vs. 8,541 Hematology-Oncology providers
+569%
Opioid rate vs peers
42.0% vs 6.3% avg
-100%
Cost per patient vs peers
$17 vs $14K avg
+99%
Brand preference vs peers
29.0% vs 14.6% avg
⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.
🔎 Data Overview
Opioid prescribing rate is 569% above the average for Hematology-Oncology providers. While some providers legitimately treat pain-heavy populations, deviations of this magnitude are rare and warrant examination.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
42.0%
Opioid Rate
94
Opioid Claims
$245
Opioid Cost
—
Long-Acting Rate
This provider's opioid prescribing rate of 42.0% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 65 claims · $791
Generic: 159 claims · $1,353
Patient Profile
73
Avg Age
77%
Female
1.69
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About